Age-associated Toll-like receptor dysfunction in the lungs
Age-associated Toll-like receptor dysfunction in the lungs
批准号:
7790552
负责人:
Carlos J Orihuela
金额:
$15.07万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2012-03-31
关键词:
AffectAgeAge-MonthsAge-YearsAgingAlveolar MacrophagesAnimalsCase Fatality RatesCause of DeathCell Adhesion MoleculesCell AgingCell SeparationCellsClinicalCommunitiesCoughingCritical CareCytokine ActivationDiseaseDisease OutcomeDyspneaElderlyEpithelial CellsEventExhibitsFeverFunctional disorderGoalsHourHumanImmune responseIncidenceInfectionInflammatoryInterleukin-6InterventionInvadedLaboratoriesLeukocyte Adhesion MoleculesLeukocyte-Adhesion ReceptorsLeukocytesLifeLigandsLungLung InflammationMeasuresMediatingMessenger RNAMolecularMusNatural ImmunityNuclearOutcomePatternPattern RecognitionPeptidoglycanPhagocytesPhosphorylationPneumococcal InfectionsPneumococcal PneumoniaPneumoniaPredispositionPreventive MedicineProductionProteinsReceptor CellReceptor SignalingReportingRespiratory SystemRespiratory tract structureRodentSignal TransductionSignaling MoleculeSignaling ProteinStreptococcus pneumoniaeStreptococcus pneumoniae plY proteinSymptomsThioglycolatesTimeToll-Like Receptor 1Toll-Like Receptor 2Toll-like receptorsTumor Necrosis Factor-alphaTumor Necrosis FactorsUnited StatesWestern Blottingage effectage relatedagedalveolar type II cellantimicrobialbasecell agecell typecytokineexperiencehuman IRAK1 proteinimprovedmacrophagemeetingsmicroorganismneutrophilpathogenpneumocyteprognostic indicatorpublic health relevancereceptor expressionresearch studyresponsetoll-like receptor 4
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Community-acquired pneumonia (CAP) is a leading cause of death among the elderly (>65 years); despite access to antimicrobials and supportive critical care, the case-fatality rate for elderly with CAP is 15-30%. Toll- like receptors (TLR) are pattern recognition molecules that identify molecular patterns associated with invading microorganisms and initiate the innate immune response (e.g. NFkB activation, cytokine production). It is now evident that aging is associated with TLR dysfunction; phagocytes isolated from aged animals exhibit decreased TLR expression, impaired TLR signaling, and a reduction in TLR-mediated cytokine production. Currently the impact of age-dependent TLR dysfunction (ADTD) in the lungs is unknown. However, ADTD may help explain: 1) why CAP is more severe in the elderly; 2) why 10% of the elderly with pneumonia show no overt clinical signs of infection such as fever, cough, or dyspnea; and 3) why lack of fever is a prognostic indicator of poor clinical outcome. We hypothesize that ADTD occurs in lungs of aged animals and that it increases susceptibility to pneumonia. Laboratory observations that support this hypothesis include: 1) decreased TLR-1, -2, and -4 protein levels in the lungs of aged mice versus young mice; 2) aged mice infected with Streptococcus pneumoniae develop fulminate pneumonia and die within 36 hours whereas young mice remain relatively healthy; 3) diminished NFkB activation in the lungs of aged mice during infection; and 4) reduced TNF1 and IL-6 levels in the lungs of aged mice following tracheal challenge with S. pneumoniae components. The focus of this proposal is ADTD in the lungs during pneumonia. We will: Aim 1: Determine the effects of aging on TLRs and TLR signaling protein levels. Using Real Time (RT)- PCR, quantitative Western blot, and FACs analysis we will determine if mRNA and protein levels of TLRs 1-9, and the TLR cell signaling molecules Myd88, IRAK-1, and IRAK-4 are decreased in alveolar macrophages and type II pneumocytes (lung mucosal epithelial cells) isolated from aged versus young and mature mice. Aim 2: Determine the effects of aging on the TLR response to S. pneumoniae components in the lung. Using primary lung cells and live mice, we will determine the effects of aging on phosphorylation of the TLR cell signaling protein IRAK-1, NFkB activation, cytokine production, and expression of leukocyte adhesion molecules in response to peptidoglycan and pneumolysin, TLR-2 and TLR-4 ligands, respectively. -Completion of this proposal will expand our understanding of ADTD to include alveolar macrophages and mucosal epithelial cells, the primary point of contact for respiratory tract pathogens in the lungs. Proposed experiments may determine that ADTD is a principal mechanism responsible for the increased susceptibility of the elderly to pneumonia. This project meets established NIA goals of examining the effects of age-related changes on functional disease outcomes. PUBLIC HEALTH RELEVANCE: Toll-like receptors (TLR) recognize invading microorganisms and initiate the host innate immune response. Evidence collected in our laboratory indicates that age-dependent TLR dysfunction (ADTD) occurs in the lungs. This proposal will determine if alveolar macrophages and mucosal epithelial cells, the primary point of contact for respiratory tract pathogens in the lungs, experience ADTD.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.exger.2014.01.007
发表时间:
2014-06
期刊:
EXPERIMENTAL GERONTOLOGY
影响因子:
3.9
作者:
[Hinojosa, Cecilia A., Babu, Ramya Akula Suresh, Rahman, Md M., Fernandes, Gabriel, Boyd, Angela R., Orihuela, Carlos J.]
通讯作者:
Orihuela, Carlos J.
DOI:
10.1111/j.1474-9726.2011.00720.x
发表时间:
2011-10
期刊:
Aging cell
影响因子:
7.8
作者:
[Shivshankar P, Boyd AR, Le Saux CJ, Yeh IT, Orihuela CJ]
通讯作者:
Orihuela CJ
DOI:
10.1111/j.1440-1843.2010.01814.x
发表时间:
2010-10
期刊:
Respirology (Carlton, Vic.)
影响因子:
--
作者:
[Paterson GK, Orihuela CJ]
通讯作者:
Orihuela CJ
DOI:
--
发表时间:
2011
期刊:
Aging and disease
影响因子:
7.4
作者:
[Boyd,AngelaR, Orihuela,CarlosJ]
通讯作者:
Orihuela,CarlosJ
DOI:
10.1186/1471-2180-12-73
发表时间:
2012-05-15
期刊:
BMC microbiology
影响因子:
4.2
作者:
[Boyd AR, Hinojosa CA, Rodriguez PJ, Orihuela CJ]
通讯作者:
Orihuela CJ
Cardiomyocyte self-defense against Streptococcus pneumoniae
-
批准号:10639102
-
项目类别:
-
资助金额:$17.97万
-
财政年份:2023
-
负责人:Carlos J Orihuela
-
依托单位:
Molecular mechanisms underlying organ penetration in disseminated pneumococcal infection
-
批准号:10555548
-
项目类别:
-
资助金额:$65.71万
-
财政年份:2022
-
负责人:Carlos J Orihuela
-
依托单位:
PspA binds necroptotic cells to cause disease and transmit
-
批准号:10269932
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2020
-
负责人:Carlos J Orihuela
-
依托单位:
PspA binds necroptotic cells to cause disease and transmit
-
批准号:10470379
-
项目类别:
-
资助金额:$40.77万
-
财政年份:2020
-
负责人:Carlos J Orihuela
-
依托单位:
PspA binds necroptotic cells to cause disease and transmit
-
批准号:10685976
-
项目类别:
-
资助金额:$41.02万
-
财政年份:2020
-
负责人:Carlos J Orihuela
-
依托单位:
Inhibition of necroptosis during inflamm-aging and pneumonia
-
批准号:9248088
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2016
-
负责人:Carlos J Orihuela
-
依托单位:
Cardiac microlesion formation during invasive pneumococcal disease
-
批准号:9179589
-
项目类别:
-
资助金额:$36.43万
-
财政年份:2015
-
负责人:Carlos J Orihuela
-
依托单位:
Cardiac microlesion formation during invasive pneumococcal disease
-
批准号:10307592
-
项目类别:
-
资助金额:$43.72万
-
财政年份:2014
-
负责人:Carlos J Orihuela
-
依托单位:
Cardiac microlesion formation during invasive pneumococcal disease
-
批准号:10517516
-
项目类别:
-
资助金额:$44.48万
-
财政年份:2014
-
负责人:Carlos J Orihuela
-
依托单位:
Cardiac microlesion formation during invasive pneumococcal disease
-
批准号:9891766
-
项目类别:
-
资助金额:$45.55万
-
财政年份:2014
-
负责人:Carlos J Orihuela
-
依托单位:
Statins protect against adverse cardiac events during pneumonia
-
批准号:8245700
-
项目类别:
-
资助金额:$18.6万
-
财政年份:2011
-
负责人:Carlos J Orihuela
-
依托单位:
Statins protect against adverse cardiac events during pneumonia
-
批准号:8094796
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2011
-
负责人:Carlos J Orihuela
-
依托单位:
Mechanism of PsrP mediated adhesion
-
批准号:7995950
-
项目类别:
-
资助金额:$25.47万
-
财政年份:2009
-
负责人:Carlos J Orihuela
-
依托单位:
Mechanism of PsrP mediated adhesion
-
批准号:7759609
-
项目类别:
-
资助金额:$25.73万
-
财政年份:2009
-
负责人:Carlos J Orihuela
-
依托单位:
Mechanism of PsrP mediated adhesion
-
批准号:8423395
-
项目类别:
-
资助金额:$23.94万
-
财政年份:2009
-
负责人:Carlos J Orihuela
-
依托单位:
Mechanism of PsrP mediated adhesion
-
批准号:7654374
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2009
-
负责人:Carlos J Orihuela
-
依托单位:
Mechanism of PsrP mediated adhesion
-
批准号:8204783
-
项目类别:
-
资助金额:$25.47万
-
财政年份:2009
-
负责人:Carlos J Orihuela
-
依托单位:
Age-associated inflammation increases susceptibility to pneumococcal infection
-
批准号:7385278
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2007
-
负责人:Carlos J Orihuela
-
依托单位:
Age-associated inflammation increases susceptibility to pneumococcal infection
-
批准号:7502167
-
项目类别:
-
资助金额:$15.2万
-
财政年份:2007
-
负责人:Carlos J Orihuela
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: